Skip to main content
Equibles

PERCEPTIVE ADVISORS LLC

Position in ZYME — Zymeworks Inc.

CIK 1224962 NEW YORK, NY
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$109,342,391
+$21,450,038 QoQ
Shares Held
4,182,953
+19.2% QoQ
Ownership
5.89%
of shares outstanding
% of Portfolio
1.76%
of 13F equity value
Holder Rank
#4
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,490,398,452 across 69 Biotechnology names. ZYME ranks #17 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 2,035,986 $681,627,752
2 SYRE
Spyre Therapeutics, Inc.
 4,319,496 $383,484,854
3 CELC
Celcuity Inc.
 3,197,200 $334,491,064
4 ASND
Ascendis Pharma A/S
 1,163,721 $310,387,665
5 RYTM
Rhythm Pharmaceuticals, Inc.
 2,586,295 $287,156,333
6 ROIV
Roivant Sciences Ltd.
 8,085,461 $286,144,464
7 RLAY
Relay Therapeutics, Inc.
 14,106,187 $263,926,758
8 TVTX
Travere Therapeutics, Inc.
 3,752,574 $213,183,728

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $109,342,391 4,182,953
2026-03-31 $87,892,353 3,510,078
2025-12-31 $85,884,510 3,261,850
2025-09-30 $35,708,524 2,090,663
2025-06-30 $16,004,688 1,275,274
2025-03-31 $22,208,243 1,864,672
2024-12-31 $31,183,492 2,130,020
2024-09-30 $27,359,251 2,180,020
2024-06-30 $14,192,220 1,667,711
2024-03-31 $11,306,969 1,074,807
2023-12-31 $11,167,244 1,074,807
2023-09-30 $9,168,419 1,446,123
2023-06-30 $20,876,244 2,416,232
2023-03-31 $30,541,621 3,378,498
2022-12-31 $35,458,621 4,511,275